Market World Next Generation Sequencing Market | Page 3

expected to show a substantial demand over the forecast period on account of increasing emphasis by the
regional government on healthcare facilities coupled with the stringent regulatory framework. Asia Pacific and
the Middle East are expected to observe significant growth on account of the increasing government initiatives
to establish proper healthcare infrastructure in developing economies including China, India, Japan and UAE.
The NGS market is dominated by few players with the help of proprietary platforms. The key industry players
include Life Sciences (Roche), Thermo Fischer Scientific, Illumina and Pacific Biosciences. Other major players
operating in the market include Partek Inc., Genomatix Software GmbH, Macrogen Inc., Life Technologies Corp,
Perkin Elmer inc., Oxford Nanopore Technologies Ltd., Knome Inc, Agilent Technologies Inc., Biomatters Ltd.,
CLC Bio (Qiagen), Pacific Biosciences, BGI (Beijing Genomics Institute), DNASTAR Inc, GATC Biotech and Qiagen
N.V.
Market Segmentation
NGS Outlook, by Application (Revenue, USD Million; 2014 - 2025)
• Reproductive Health
• NIPT
• PGT
• Newborn/Genetic Screening
• Oncology
• HLA Typing/Immune System Monitoring
• Metagenomics, Epidemiology & Drug Development
• Agrigenomics & Forensics
• Consumer Genomics
• Clinical Investigation
• Idiopathic Diseases
• Inherited Diseases
• Infectious Diseases
• Non-Communicable / Other Diseases
NGS Outlook, by Technology (Revenue, USD Million; 2014 - 2025)
• Targeted Sequencing Analysis
• DNA Based Targeted Sequencing Analysis
• RNA Based Targeted Sequencing Analysis
• Whole Genome Sequencing
• Whole Exome Sequencing